Truesdale A, Bakhai A, Wang D. (2006). Multicenter trials. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 153-163.
Wang D & Bakhai A, editors. (2006). Clinical Trials: A Practical Guide to Design, Analysis and Reporting. London: Remedica.
Wang D, Bakhai A. (2006a). Randomization. In: D Wang & A Bakhai, (Ed.s).
Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 65-73.
Wang D, Bakhai A. (2006b). Sample Size and Power. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 81-87.
Wang D, Arezina R, Bakhai A. (2006a). Bioequivalence Trials. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 119-130.
Wang D, Clayton T, Bakhai A. (2006b). Analysis of Survival Data. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 235-254.
Wang D. Clayton T, Bakhai A. (2006c). Confounding. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 295-304.
Wang D, Clayton T, Clemens F. (2006d). Comparison of Proportions. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 217-234.
Wang D, Clayton T, Yan H. (2006e). Significance Tests and Confidence Intervals. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 185-196.
Wang D, Clemens F, Clayton T. (2006f). Comparison of Means. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 197-216.
Wang D, Lorch U, Bakhai A. (2006g). Crossover Trials. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 91-99.
Yusuf S, Zhao F, Mehta SR et al. (2001). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med;345: 494–502.